|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.088 EUR | +0.60% |
|
+0.33% | -15.07% |
| 05:25pm | Grifols Launches Fesilty in the U.S | CI |
| 04:45pm | Grifols Launches Fesilty Blood Clotting Concentrate in US | MT |
MarketScreener Strategies
Search
 | Grifols' Insatiable Appetite | May 26, 2026 at 01:19 pm |
 | Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy | May 08, 2026 at 07:04 pm |
| Grifols: May struggle to walk the talk | April 06, 2026 at 09:11 am |
 | Grifols: IPO plans for a subsidiary don't smell right | March 27, 2026 at 07:21 pm |
| Grifols: Decent end to 2025, but suspicions rise over future execution abilities | February 27, 2026 at 10:33 pm |
| Grifols lifts 2025 targets but fibrinogen delay and forex drag weigh on outlook | November 06, 2025 at 02:01 pm |
 | Gotham City sets its sights on Grifols | January 09, 2024 at 07:09 pm |
No results match your criteria
Filters
- Stock Market
- Stocks
- GRF Stock
- News Grifols, S.A.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition